These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 3281007

  • 1. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.
    Brandt SJ, Peters WP, Atwater SK, Kurtzberg J, Borowitz MJ, Jones RB, Shpall EJ, Bast RC, Gilbert CJ, Oette DH.
    N Engl J Med; 1988 Apr 07; 318(14):869-76. PubMed ID: 3281007
    [Abstract] [Full Text] [Related]

  • 2. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
    Antman KS, Griffin JD, Elias A, Socinski MA, Ryan L, Cannistra SA, Oette D, Whitley M, Frei E, Schnipper LE.
    N Engl J Med; 1988 Sep 08; 319(10):593-8. PubMed ID: 3045544
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation.
    Elkordy M, Crump M, Vredenburgh JJ, Petros WP, Hussein A, Rubin P, Ross M, Gilbert C, Modlin C, Meisenberg B, Coniglio D, Rabinowitz J, Laughlin M, Kurtzberg J, Peters WP.
    Bone Marrow Transplant; 1997 Feb 08; 19(4):315-22. PubMed ID: 9051240
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
    Laughlin MJ, Kirkpatrick G, Sabiston N, Peters W, Kurtzberg J.
    Ann Hematol; 1993 Dec 08; 67(6):267-76. PubMed ID: 7506580
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model.
    Nienhuis AW, Donahue RE, Karlsson S, Clark SC, Agricola B, Antinoff N, Pierce JE, Turner P, Anderson WF, Nathan DG.
    J Clin Invest; 1987 Aug 08; 80(2):573-7. PubMed ID: 3301903
    [Abstract] [Full Text] [Related]

  • 9. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 08; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 10. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM, Bierman PJ, Ruby E, Reed EC, Bishop MR, Tarantolo S, Kessinger A, Armitage JO.
    Bone Marrow Transplant; 1996 Jun 08; 17(6):951-6. PubMed ID: 8807099
    [Abstract] [Full Text] [Related]

  • 11. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
    Lieschke GJ, Maher D, O'Connor M, Green M, Sheridan W, Rallings M, Bonnem E, Burgess AW, McGrath K, Fox RM.
    Cancer Res; 1990 Feb 01; 50(3):606-14. PubMed ID: 2404573
    [Abstract] [Full Text] [Related]

  • 12. Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.
    Grigg A, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM, Sheridan WP.
    Bone Marrow Transplant; 1993 Feb 01; 11 Suppl 2():23-9. PubMed ID: 8334435
    [Abstract] [Full Text] [Related]

  • 13. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation.
    Peters WP, Kurtzberg J, Atwater S, Borowitz M, Rao M, Currie M, Gilbert C, Shpall EJ, Jones RB, Ross M.
    Prog Clin Biol Res; 1990 Feb 01; 338():121-8. PubMed ID: 2189135
    [No Abstract] [Full Text] [Related]

  • 14. Enhanced myelopoiesis in long-term cultures of human bone marrow pretreated with recombinant granulocyte-macrophage colony-stimulating factor.
    Haas R, Ogniben E, Kiesel S, Hohaus S, Baumann M, Körbling M, Dörken B, Hunstein W.
    Exp Hematol; 1989 Mar 01; 17(3):235-9. PubMed ID: 2645156
    [Abstract] [Full Text] [Related]

  • 15. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
    Brandwein JM, Nayar R, Baker MA, Sutton DM, Scott JG, Sutcliffe SB, Keating A.
    Exp Hematol; 1991 Mar 01; 19(3):191-5. PubMed ID: 1995310
    [Abstract] [Full Text] [Related]

  • 16. Clinical role of granulocyte-macrophage colony-stimulating factor.
    Mitsuyasu RT, Golde DW.
    Hematol Oncol Clin North Am; 1989 Sep 01; 3(3):411-25. PubMed ID: 2698875
    [Abstract] [Full Text] [Related]

  • 17. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.
    Haematologica; 1997 Sep 01; 82(3):291-6. PubMed ID: 9234574
    [Abstract] [Full Text] [Related]

  • 18. Administration of human recombinant granulocyte colony-stimulating factor (filgrastim) accelerates granulocyte recovery following high-dose chemotherapy and autologous marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow in women with metastatic breast cancer.
    Kennedy MJ, Davis J, Passos-Coelho J, Noga SJ, Huelskamp AM, Ohly K, Davidson NE.
    Cancer Res; 1993 Nov 15; 53(22):5424-8. PubMed ID: 7693341
    [Abstract] [Full Text] [Related]

  • 19. A phase I trial of interleukin 3 (IL-3) pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumors receiving high-dose combination chemotherapy.
    Sosman JA, Stiff PJ, Bayer RA, Peliska J, Peace DJ, Loutfi S, Stock W, Oldenburg D, Unverzagt K, Bender J.
    Bone Marrow Transplant; 1995 Nov 15; 16(5):655-61. PubMed ID: 8547862
    [Abstract] [Full Text] [Related]

  • 20. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor.
    Vadhan-Raj S, Buescher S, Broxmeyer HE, LeMaistre A, Lepe-Zuniga JL, Ventura G, Jeha S, Horwitz LJ, Trujillo JM, Gillis S.
    N Engl J Med; 1988 Dec 22; 319(25):1628-34. PubMed ID: 3059191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.